Skip to main content

Novel nanoparticles for drug delivery to the skin

Objective

The aim of the NANODRUG Network is to contribute to the defragmentation of the emerging field of nanomedicine by providing a unique training programme that will cover all different aspects ranging from NP synthesis and characterisation, drug delivery, molecular biology to nanotoxicology, preclinical studies, risk assessment and nanotechnology policy making. The NANODRUG training program is far superior to any training that individual partners can provide and will equip researchers with innovative and creative skills and enhance their career prospects in the public and private sectors. The scientific aim of this research training network is to develop and characterise a selected set of novel intelligent nanomaterials and to study their suitability as novel drug delivery systems targeting inflammatory skin diseases. The development and use of the NP described in this project aims to overcome the current difficulties that limit the applications of NP to skin drug delivery. The unique physico-chemical properties of these novel NP such as ultra small size, large surface to mass ratio, high reactivity and the capability to tailor them to applications will ensure that when complexed with drugs the pharmacokinetics and therapeutic index of the delivery systems can be significantly improved compared to the free molecules and the capability to pass the SC of the skin greatly enhanced. This project brings together 6 academic groups and 2 industrial teams as full partners, complemented by 3 associate partners, one of which is an industrial team, distributed over a total of 6 EU member states and 1 non-ICPC country. The consortium brings together groups with a very interdisciplinary expertise ranging from polymer synthesis and characterisation, computational modelling and physicochemical characterisation of materials to bioavailability, NP formulation, drug distribution and nanotoxicity, genetics, drug delivery and clinical dermatology.

Call for proposal

FP7-PEOPLE-2011-ITN
See other projects for this call

Coordinator

QUEEN MARY UNIVERSITY OF LONDON
Address
327 Mile End Road
E1 4NS London
United Kingdom

See on map

Activity type
Higher or Secondary Education Establishments
Administrative Contact
Marina Resmini (Dr.)
EU contribution
€ 1 136 970,90

Participants (7)

CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS
France
EU contribution
€ 570 952,70
Address
Rue Michel Ange 3
75794 Paris

See on map

Activity type
Research Organisations
Administrative Contact
Gilles Pulvermuller (Mr.)
SANOFI-AVENTIS RECHERCHE & DEVELOPPEMENT
France
EU contribution
€ 497 985,60
Address
Pierre Brossolette 1
91380 Chilly Mazarin

See on map

Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Administrative Contact
Christophe Labie (Dr.)
UNIVERSITAET INNSBRUCK
Austria
EU contribution
€ 269 690,80
Address
Innrain 52
6020 Innsbruck

See on map

Activity type
Higher or Secondary Education Establishments
Administrative Contact
Klaus Liedl (Prof.)
CRANFIELD UNIVERSITY
United Kingdom
EU contribution
€ 293 458,71
Address
College Road
MK43 0AL Cranfield - Bedfordshire

See on map

Activity type
Higher or Secondary Education Establishments
Administrative Contact
Zhu Huijun (Dr.)
CENTRO DE NEUROCIENCIAS E BIOLOGIACELULAR ASSOCIACAO
Portugal
EU contribution
€ 471 627,60
Address
Universidade De Coimbra Largo Marques De Pombal
3004 517 Coimbra

See on map

Activity type
Research Organisations
Administrative Contact
Lino Ferreira (Dr.)
MJR PHARMJET GMBH
Germany
EU contribution
€ 254 614,41
Address
Industriestrasse 1b
66802 Uberherrm

See on map

Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Administrative Contact
Akif Emre Türeli (Mr.)
UNIVERSITE CATHOLIQUE DE LOUVAIN
Belgium
EU contribution
€ 257 451,90
Address
Place De L Universite 1
1348 Louvain La Neuve

See on map

Activity type
Higher or Secondary Education Establishments
Administrative Contact
Veronique Preat (Prof.)